BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MUJHU Research Collaboration - ECPv5.12.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MUJHU Research Collaboration
X-ORIGINAL-URL:https://www.mujhu.org
X-WR-CALDESC:Events for MUJHU Research Collaboration
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20240529T070000
DTEND;TZID=UTC:20240529T090000
DTSTAMP:20260417T190427
CREATED:20240522T074541Z
LAST-MODIFIED:20240522T074541Z
UID:10663-1716966000-1716973200@www.mujhu.org
SUMMARY:HIP-CY Study Stakeholder Breakfast Meeting
DESCRIPTION:
URL:https://www.mujhu.org/event/hip-cy-study-stakeholder-breakfast-meeting/
LOCATION:MUJHU Research Collaboration\, Mulago\, Kampala\, Uganda
ORGANIZER;CN="MU-JHU%20Care%20Ltd%20%7C%20MU-JHU%20Research%20Collaboration":MAILTO:rnabbosa@mujhu.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231109T130000
DTEND;TZID=UTC:20231109T150000
DTSTAMP:20260417T190427
CREATED:20231103T134645Z
LAST-MODIFIED:20231103T140752Z
UID:10261-1699534800-1699542000@www.mujhu.org
SUMMARY:DXA Webinar
DESCRIPTION:MU-JHU Care Ltd. in association with the Uganda Medical Association Central Branch Executive Committee is pleased to invite you to a virtual CPD event.\nTopic: Bone Mineral Density\, Bone Quality & Body Composition: The Role of DXA Imaging\nDate: 09 November 2023 (Thursday)\nTime: 4:00PM-6:00PM (EAT)\n \nZoom Link:\nhttps://us02web.zoom.us/j/86155658476?pwd=dFhvVHloQVVNT3FTOW5SRDk4UVpndz09 \nCoordinated by:\nDr. Mathias Lubega \nCPD Chair-UMA Central Branch Executive Committee & Medical Officer-MUJHU Research Collaboration
URL:https://www.mujhu.org/event/10261/
ATTACH;FMTTYPE=image/png:https://www.mujhu.org/wp-content/uploads/2023/11/DXA-Webinar_Nov-2023_9th4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230810T060000
DTEND;TZID=UTC:20230810T110000
DTSTAMP:20260417T190427
CREATED:20230802T051647Z
LAST-MODIFIED:20230802T075405Z
UID:9898-1691647200-1691665200@www.mujhu.org
SUMMARY:Annual BD Surveillance Stakeholders Meeting
DESCRIPTION:
URL:https://www.mujhu.org/event/9898/
ATTACH;FMTTYPE=image/png:https://www.mujhu.org/wp-content/uploads/2023/08/General.png
ORGANIZER;CN="MU-JHU%20Care%20Ltd":MAILTO:rmboizi@mujhu.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230512T074500
DTEND;TZID=UTC:20230512T130000
DTSTAMP:20260417T190427
CREATED:20230505T112540Z
LAST-MODIFIED:20230505T150014Z
UID:9729-1683877500-1683896400@www.mujhu.org
SUMMARY:Vaccines in Pregnancy and Infancy: National Stakeholders Meeting
DESCRIPTION:The Makerere University-Johns University Research Collaboration (MU-JHU) in partnership with St Georges University London (SGUL) is inviting you to a special stakeholder meeting to discuss current study findings and future vaccine research in pregnant women and infants in Uganda. \nThe investigators will present updates on current studies within the portfolio and proposed vaccine and observational studies. You will be given an opportunity to ask questions and discuss issues related to vaccination in pregnancy and infancy. \nSeveral studies have been underway with your support since 2018 to set the scene for maternal and infant vaccine clinical trials in Uganda. These include: \n\nThe PROGRESS study\, to determine the incidence of Group B Streptococcal disease (GBS)\, colonization and neurodevelopmental impairment following infant disease. This study also includes a comprehensive overview of other pathogens that cause disease in the first months of life for which vaccines are or will soon be available to be given to pregnant women or their infants. This study will complete follow up in September 2023.\nThe WOMANPOWER study\, to determine the safety and efficacy of a pertussis-containing vaccine (TDaP) given to pregnant women living with HIV. This study has completed and interim results are available.\nThe PREPARE studies: This includes the development of a pregnancy exposures registry and background rates of adverse events in sentinel sites that has also been used to monitor adverse events in pregnancy and infancy during the COVID-19 pandemic (periCOVID study). Pfizer Multivalent CPS-conjugate vaccine trial in pregnant HIV-infected and uninfected women investigating the safety and immunogenicity of the vaccine in pregnant women and the subsequent transfer of vaccine induced antibodies to their infants. Minervax GBS vaccine trial in pregnant HIV-infected and uninfected women investigating the safety and immunogenicity of the vaccine in pregnant women and the subsequent transfer of vaccine induced antibodies to their infants. This programme of work also includes a large component of vaccine hesitancy work. Updates will be presented on progress to date.\n\nWe will also take the opportunity to update you on upcoming studies within the portfolio and seek your input. These include: \n\nMeasles remains a common cause of morbidity and mortality in infants under five years worldwide\, with occurrence substantially noted in regions with low vaccination rates. While it is generally believed infants are protected by maternal antibodies for 6-9 months\, an over representation of infants under 6 months has been shown in recent outbreaks. Vaccination of infants earlier than the standard 9months with a booster dose may confer protection to these children earlier.BoostME trial: Earlier prime-boost schedule to improve measles protection in\nhigh burden settings.\nA study to investigate risk factors that could be incorporated into routine care to prevent severe infant infection in the first days of life.The studies are conducted at the Several KCCA facilities including Kawempe National Referral Hospital\, Kisenyi health centre IV\, Kawala and Komomboga and others by investigators from MU-JHU and SGUL through the EDCTP\, Medical Research Council and Bill and Belinda Gates Foundation funding.\n\nSession facilitators\n\nProf. Kirsty Le Doare\nDr. Eve Nakabembe\nDr. Robert Mboizi\nDr. Solomon Kamurari\nDr. Hannah Davis\nDr. Ouma Joseph\nDr. Geoff Kitson\nDr. Mary Kyohere\nDr. Alexander Amone\nDr. Gerald Businge\nDr. Lauren Hookham\nDr. Agnes Ssali\nVictoria Nambasa\nAnthony Ssebagereka\nEsther Imede\nSarah Sturrock\nPhiona  Nalubega\nRitah Namugumya\n\nJoin Zoom Meeting:\nhttps://us02web.zoom.us/j/88596947058?pwd=SHFUOHljTnpHMWxKd0VjcmR5emsrQT09\nMeeting ID: 885 969
URL:https://www.mujhu.org/event/vaccines-in-pregnancy-and-infancy-national-stakeholders-meeting/
ATTACH;FMTTYPE=image/jpeg:https://www.mujhu.org/wp-content/uploads/2023/05/PREPARE-meeting-poster-scaled.jpg
ORGANIZER;CN="MU-JHU%20Care%20Ltd":MAILTO:rmboizi@mujhu.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230324T090000
DTEND;TZID=UTC:20230324T103000
DTSTAMP:20260417T190427
CREATED:20230316T151155Z
LAST-MODIFIED:20230321T061530Z
UID:9456-1679648400-1679653800@www.mujhu.org
SUMMARY:Workshop on Funding Opportunities
DESCRIPTION:Please follow this link to register attendance: https://forms.gle/S7UrXGnSSZ76NinY8
URL:https://www.mujhu.org/event/workshop-on-funding-opportunities/
ATTACH;FMTTYPE=image/jpeg:https://www.mujhu.org/wp-content/uploads/2023/03/Poster-MRC-Workshop_All-logos-scaled.jpg
ORGANIZER;CN="MU-JHU%20Care%20Ltd":MAILTO:rmboizi@mujhu.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230316T080000
DTEND;TZID=UTC:20230317T163000
DTSTAMP:20260417T190427
CREATED:20230315T151657Z
LAST-MODIFIED:20230316T152453Z
UID:9446-1678953600-1679070600@www.mujhu.org
SUMMARY:IMPAACT 2036 REGIONAL TRAINING- BY INVITATION ONLY
DESCRIPTION:Poster- IMPAACT Training Poster
URL:https://www.mujhu.org/event/impaact-2036-regional-training/
LOCATION:MUJHU Research Collaboration\, Mulago\, Kampala\, Uganda
ATTACH;FMTTYPE=image/png:https://www.mujhu.org/wp-content/uploads/2023/03/IMPAACT2036-Primary-1_0.png
ORGANIZER;CN="MU-JHU%20Care%20Ltd%20%7C%20MU-JHU%20Research%20Collaboration":MAILTO:rnabbosa@mujhu.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220706T080000
DTEND;TZID=UTC:20220706T120000
DTSTAMP:20260417T190427
CREATED:20220510T075510Z
LAST-MODIFIED:20220613T062348Z
UID:5639-1657094400-1657108800@www.mujhu.org
SUMMARY:SHINE Trial Results Dissemination Meeting
DESCRIPTION:The SHINE Trial Stakeholders Dissemination Meeting\nTreatment length reduced for children with Tuberculosis\nThe SHINE trial exploring the effectiveness of tuberculosis (TB) treatment in children has led to a change in the World Health Organisation’s global guidelines for managing the disease. The research found that the treatment duration for the majority of children with drug-sensitive tuberculosis can be shortened from six to four months\, thereby reducing the burden on families and healthcare systems around the world. \nLead Investigator at the Ugandan site\, Dr. Eric Wobudeya will be meeting with the scientific community in Uganda to share the details of the study and discuss the implications  [date and time of meeting to be announced] . \nResearchers from the MRC Clinical Trials Unit at UCL worked with partners in Uganda\, South Africa\, Zambia and India on the SHINE study\, the first randomised control trial to assess whether children with ‘minimal’ TB could be effectively treated with a shorter course of treatment. \nThe trial involved 1\,204 children aged from two months up to 16 years with non-severe TB\, who were divided randomly into two groups to take either four or six months of treatment with anti-TB medicines. Of the enrolled children\, 11% were living with HIV. All children were followed for 18 months after enrolment to see whether their treatment had been successful. \nThe results clearly showed that children who received the shorter course did as well as those on the standard six-month treatment\, regardless of the age group\, country or HIV status\, with few and similar side effects in both groups. \nThe World Health Organisation Guidelines Development Group reviewed the evidence from SHINE and recommended in August 2021 that presumed drug susceptible TB\, a four-month regimen should be used rather than the standard six-month regimen in children and adolescents with non-severe. \nImportant considerations about how to determine eligibility for the shorter treatment regimen will be described in WHO’s full consolidated guidelines coming out in 2022 and in the operational handbook. \n  \nAbout SHINE\nThe SHINE trial was funded by the Joint Global Health Trials scheme\, including the Department for Health and Social Care\, the Foreign\, Commonwealth and Development Office\, the Medical Research Council and the Wellcome Trust. This UK-funded award is part of the EDCTP2 Programme supported by the European Union. \nAdditional partners included Stellenbosch University\, South Africa; University of Cape Town\, South Africa; National Institute for Research in Tuberculosis\, India; Radboud University Medical Center\, the Netherlands; International Union Against Tuberculosis and Lung Disease\, France; University of Melbourne\, Australia; University of York; Imperial College London and University Hospitals Birmingham. \n  \nAbout MU-JHU Care Ltd\nMU-JHU Care LTD is an HIV research\, care prevention and training facility located on Upper Mulago Hill in the city of Kampala. In 1988\, we started as a collaboration between researchers from Makerere University and Johns Hopkins University in Baltimore\, USA ( US-based researchers were originally based at Case Western Reserve University). Our initial mission was to improve the lives of families infected and affected by HIV through Research\, Care and Training. Up until 2006\, we operated under the name MU-JHU Research Collaboration. In the same year\, we registered as a not-for-profit\, entity in Uganda entitled ‘MU-JHU Care Limited’ with a continuation of the Collaboration’s vision and mission. \nMU-JHU has conducted several landmark research studies\, which have informed global and national policy. These studies paved the way to eliminate mother-to-child HIV transmission and improve maternal and paediatric HIV care. Over the last decade\, MU-JHU has progressively expanded its clinical and implementation science-research portfolio to include: \n\nPrimary HIV prevention\,\nTuberculosis diagnosis and management\,\nPaediatric neuro-development assessment and interventions\,\nBirth-defects surveillance\,\nWomen’s health (including bone health and reproductive health)\,\nThe development of a maternal vaccine platform to assess Group-B Streptococcus and other promising vaccines.\n\nMU-JHU partners with many local and international academic and clinical partners to achieve its mission building on its longstanding Clinical Research Site affiliated with Johns Hopkins University. \nNotes to Editors \nFor more information or to speak to the researchers involved\, please contact \nRomana Brenda Nabbosa\, T: +256 752 307 101\, E: rnabbosa@mujhu.org
URL:https://www.mujhu.org/event/shine-trial-results-dissemination-meeting/
ATTACH;FMTTYPE=image/png:https://www.mujhu.org/wp-content/uploads/2022/05/Picture1-1.png
ORGANIZER;CN="Romana%20B.%20Nabbosa":MAILTO:rnabbosa@mujhu.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220630T090000
DTEND;TZID=UTC:20220701T123000
DTSTAMP:20260417T190427
CREATED:20220613T054124Z
LAST-MODIFIED:20220613T060043Z
UID:6987-1656579600-1656678600@www.mujhu.org
SUMMARY:TB Research Dissemination Workshop
DESCRIPTION:Mbarara Research Centre has extensive experience in TB research and several studies conducted within the Centre have just been completed. This workshop will provide an opportunity to review the latest studies conducted on tuberculosis by Epicentre and its partners to reduce the burden of this disease in Africa. Our Investigator and specialist on paediatric TB\,  Dr. Eric Wobudeya will be a part of the panel discussions during this workshop.  The workshop in English only will be broadcast live on the Epicentre website.\n\n\n\n\n \nDiscover the program and the registration link below\n\n\n\n\n\n\n\nhttps://epicentre.msf.org/en/news/tb-research-dissemination-workshop
URL:https://www.mujhu.org/event/tb-research-dissemination-workshop/
CATEGORIES:Partnerships
ATTACH;FMTTYPE=image/jpeg:https://www.mujhu.org/wp-content/uploads/2022/06/TB-Symposium.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220520T140000
DTEND;TZID=UTC:20220530T180000
DTSTAMP:20260417T190427
CREATED:20220510T073647Z
LAST-MODIFIED:20220602T105647Z
UID:5607-1653055200-1653933600@www.mujhu.org
SUMMARY:Clothed With Protection
DESCRIPTION:“Clothed with Protection” Art Project\nCommunity Sensitization on the Importance of Maternity Vaccination\n  \nUK installation artist Luke Jerram is commissioning 10 young and dynamic Ugandan fashion designers in a new art project to promote vaccination in pregnant women across Africa. This collaboration is supported by the University of Southampton in the UK\, MU-JHU Care Ltd and funded by the IMPRINT Network. \nJust as clothing protects us from the outside world\, whether from extreme temperature\, rain or abrasion\, so vaccinations create a layer of protection from infection. \n“Clothed with Protection” aims to create awareness of the benefits of vaccines given during pregnancy to reduce illness and deaths in mothers and babies.  During the later stages of pregnancy\, antibodies are transferred across the placenta from mother to child. The message of our project is that vaccination in pregnancy boosts this natural process\, providing protection to the infant in the early weeks of life. \n“Vaccines given to pregnant women are safe and protect both the mother and the newborn baby from infections during the first vulnerable months of life.”  ~Dr. Chrissie Jones\, University of Southampton\, UK. \n“Vaccination against tetanus\, and COVID-19 are currently recommended during pregnancy in Uganda\, and in the future\, we will be able to protect against other infections that cause severe illness in babies\, such as group B streptococcus” ~Dr. Mary Kyohere\, MU-JHU Care Ltd- Uganda.  \nAs a part of this art project\, the public is welcomed to two community events where the public will view the final designer clothes and have a conversation with a maternal health expert. These events are a local Community Cypher on May 18th 2022 and a Fashion showcase on May 20th 2022. The events are being organised by IGC Fashion. \nThe selected designers have a background of creating from recycled fabric to form the astonishing apparel and other work. This organic approach will use art to communicate core maternity vaccine messages into visible impressions and stimulate conversations that will improve involvement and uptake of maternal vaccination at the local level.  Through collaborating with some of the most creative people in Uganda\, this artwork is an extraordinary opportunity to send a message to the world about the importance of vaccination. \n“I have always wanted to work with artists in Uganda on a joint global health project and this provided the perfect opportunity to talk about vaccines”~Luke Jerram\, Installation Artist \nOur fashion designer lineup includes Bobbin Case\, Fiona Kyama\, Quill Clothing\, IGC Fashion\, Idah Nandyose\, Kajebe Jacob Joshua\, Marvin Zziwa\, Msema culture\, Njola Impressions and Seamline. These designers are very committed to engaging with and equipping their community\, to improve their quality of life. \nThe body of work will also form an exhibition to tour the UK. Cinematic Media is filming the journey of this project and this film\, together with the clothing and preparatory drawings will form a touring exhibition that will be presented in major museums in the UK. \n  \n\n\n\nPress Contacts\nBlak\n+256 750 893 338\n\n\n \nRomana B. Nabbosa\n+256 752 307 101\n\n\n \nDr. Kirsty Le Doare\n+256 785 244 641\n\n\n\n  \nAbout IMPRINT Network \nIMPRINT is a network focusing on maternal and neonatal immunisation\, funded by the UK’s Global Challenges Research Fund (GCRF)\, which supports challenge-led interdisciplinary research and aims to strengthen the capacity for research and innovation within the UK and in developing countries. IMPRINT is coordinated by Network Director Prof. Beate Kampmann (London School of Hygiene and Tropical Medicine) and Co-Director Dr. Chrissie Jones (University of Southampton). \nhttps://www.imprint-network.co.uk/ \nAbout Luke Jerram \nLuke Jerram is a British installation artist. His multidisciplinary art practice involves the creation of sculptures\, installations and live artworks. Living in the UK\, but working internationally\, Jerram creates art projects\, which excite and inspire people around the world. He is currently a visiting fellow at the Faculty of Health and Applied Sciences\, the University of the West of England\, Bristol. \nhttps://www.lukejerram.com/
URL:https://www.mujhu.org/event/clothed-with-protection/
LOCATION:Uganda National Cultural Centre\, Kampala\, Uganda
ATTACH;FMTTYPE=image/jpeg:https://www.mujhu.org/wp-content/uploads/2022/05/clothed-w-protection4.jpg
ORGANIZER;CN="Blak":MAILTO:Igcommunityfashion@gmail.com
END:VEVENT
END:VCALENDAR